# Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-145
- **Status:** posted
- **Opens:** November 6, 2024
- **Closes:** January 7, 2028
- **CFDA:** 93.393
- **View on Kontrakk:** https://kontrakk.com/grants/357015

## Description

No description provided.